Decabid
Drug - Decabid
The trade name of the product as shown on the labeling.
Dosage -
TABLET, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Indecainide Hydrochloride
Multiple ingredients are in alphabetical order.
Strength -
EQ 100MG BASE
The potency of the active ingredient(s), Indecainide Hydrochloride. May repeat for multiple part products.
Applicant -
LILLY
The firm name holding legal responsibility for Decabid. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
019693
The FDA assigned number to Decabid. Format is nnnnnn.
Product Number -
003
The FDA assigned number to identify Decabid. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Dec 29, 1989
The date Decabid was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Decabid. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
DISCN
The group or category of approved drugs Decabid is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Eli Lilly And Co
The full name of the firm holding legal responsibility for the new application of Decabid.
Decabid
|
